期刊文献+

2-(咪唑并[1,2-a]吡啶-3-基)乙酸的合成工艺改进 被引量:1

Improved synthesis of 2-( imidazo[1,2-a] pyridin-3-yl) acetic acid
原文传递
导出
摘要 目的改进骨质疏松治疗药米诺膦酸的关键中间体2-(咪唑并[1,2-a]吡啶-3-基)乙酸的合成工艺。方法以反式-4-氧基-2-丁烯酸乙酯和2-氨基吡啶为起始原料,经环合、水解得到2-(咪唑并[1,2-a]吡啶-3-基)乙酸。结果与结论该合成方法首次以纯水替代有机溶剂作为反应溶剂,采用"一锅法"合成目标化合物,降低了该中间体的制备成本,而且环境友好,更适合于工业化生产。 2-( Imidazo[ 1,2-α ] pyridin-3-yl )acetic acid is the key intermediate of minnodronic acid, which was used to the treatment of osteoprosis. An improved synthetic method of 2-( imidazo[ 1,2-α] pyridin-3-yl) acetic acid(I) was designed based on the public patent literature. The intermediate was synthesized from 2- amino pyridine via" one-pot"reaction. Water was used as the reaction solvent instead of organic solvents for the first time and the total yield was up to 90. 9%. So the improved process not only reduced the costs,but also was more environmentally benign and more conducive to industrial production.
出处 《中国药物化学杂志》 CAS CSCD 2014年第1期34-36,共3页 Chinese Journal of Medicinal Chemistry
关键词 2-(咪唑并[1 2-α]吡啶-3-基)乙酸 米诺膦酸 骨质疏松 化学合成 2- ( imidazo [ 1,2-α] pyridin-3 -yl ) acetic acid minnodronic acid osteoporosis chemical synthesis
  • 相关文献

参考文献10

  • 1TAKEUCHI M, SAKAMOTO S, KAWAMUKI K, et al. Studies on novel bone resorption inhibitors. II. Synthesis and pharmacological activities of fused aza-heteroarylbisphosphonate derivatives [ J ]. Chem Pharm Bull, 1998,46( 11 ) : 1703 - 1709.
  • 2赵丽嘉,王利华,胡雅萍,徐颂,陈常青.米诺膦酸水合物[J].药物评价研究,2010,33(6):479-484. 被引量:20
  • 3姚文瑾,范鸣.治疗骨质疏松症的新药米诺膦酸[J].药学进展,2009,33(11):526-527. 被引量:12
  • 4皮士卿,赵国庆,沈润溥,陈新志.米诺膦酸二钠的合成[J].中国医药工业杂志,2004,35(4):193-194. 被引量:19
  • 5徐峰,张孝清,刘科举,等.米诺膦酸的制备方法:中国,102020676A[P].2011-04-20.
  • 6杨利民.一种高纯度的米诺磷酸及其制备方法:中国,101531681A[P].2009-09-16.
  • 7张万科,陈年根,黄剑,钟霞.2-(咪唑并[1,2-a]吡啶-3-基)乙酸的合成工艺改进[J].中国药物化学杂志,2012,22(3):209-211. 被引量:3
  • 8杨亮,郭晶.一种制备化合物2-(咪唑并[1,2-a]吡啶-3-基)乙酸的方法:中国,102603739A[P].2012-07-25.
  • 9王雪根,何凌云,陈彬辉,等.一种制备1-羟基-2-(咪唑并[1,2-a]吡啶-3-基)亚乙基-1,1-双膦酸化合物的方法:中国,102344463A[P].2012-02-08.
  • 10曹龙祥,董自波,牛彝,等.一种微波促进制备米诺膦酸中间体的方法:中国,102153550A[P].2011-08-17.

二级参考文献10

  • 1[1]Isomura Y, Takeuchi M, Abe T. Heterocyclic bisphosphonic acid derivatives as bone resorption inhibitors [P]. EP: 354806,1990-02-14. (CA 1990, 113: 24240)
  • 2[2]Yoshida Y, Moriya A, Kitamura K, et al. Response of trabecular and cortical bone turnover and bone mass and strength to bisphosphonate YH529 in ovariohysterectomized beagles with calcium restriction [J]. J Bone Miner Res, 1998, 13 (6): 1011-1022.
  • 3[3]Sasaki A, Kitimura K, Alcalde RE, et al. Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice [J]. Int J Cancer, 1998, 77 (2): 279-285.
  • 4[4]Almirante L, Mugnaini A, Friz LP, et al. Sintesi e reazioni di derivati dell' imidazolo[J]. Boll Chlm Farm, 1966, 105:32-43.
  • 5[5]Almiarante L. Synthesis and pharmacological activities of nitriles, amides, and carboxylic acid derivatives of imidazo [ 1,2-α] pyridine [J]. JMed Chem, 1969, 12 (1): 122-126.
  • 6Mori H.et al.Minodronic acid(ONO-5920/YM529)prevents decrease in bone mineral density and bone strength,and improves bone microarchitecture in ovariectomized cynomolgus monkeys[].Bone.2008
  • 7Takeuchi M,et al.Studies on novel bone resorption inhibitors.II.Synthesis and pharmacological activities of fused aza-heteroaryl bisphosphonate derivatives[].Chemical and Pharmaceutical Bulletin.1998
  • 8Tanaka M,et al.Long-term minodronic acid(ONO-5920/YM529)treatment suppresses increased bone turnover,plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia[].Bone.2008
  • 9姚文瑾,范鸣.治疗骨质疏松症的新药米诺膦酸[J].药学进展,2009,33(11):526-527. 被引量:12
  • 10皮士卿,赵国庆,沈润溥,陈新志.米诺膦酸二钠的合成[J].中国医药工业杂志,2004,35(4):193-194. 被引量:19

共引文献28

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部